Due to gene mutation, overexpression, and posttranslational modifications, aberrant mTOR activation is often detected in a significant proportion of NSCLC, which is heavily implicated in tumorigenesis and cancer progression (5). Here, MTOR is linked to non-small cell lung carcinoma.